1. Home
  2. NKTR vs PLBC Comparison

NKTR vs PLBC Comparison

Compare NKTR & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • PLBC
  • Stock Information
  • Founded
  • NKTR 1990
  • PLBC 1980
  • Country
  • NKTR United States
  • PLBC United States
  • Employees
  • NKTR N/A
  • PLBC N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • PLBC Finance Companies
  • Sector
  • NKTR Health Care
  • PLBC Finance
  • Exchange
  • NKTR Nasdaq
  • PLBC Nasdaq
  • Market Cap
  • NKTR 247.9M
  • PLBC 253.9M
  • IPO Year
  • NKTR 1994
  • PLBC 2005
  • Fundamental
  • Price
  • NKTR $0.93
  • PLBC $44.24
  • Analyst Decision
  • NKTR Strong Buy
  • PLBC Buy
  • Analyst Count
  • NKTR 5
  • PLBC 2
  • Target Price
  • NKTR $4.50
  • PLBC $57.00
  • AVG Volume (30 Days)
  • NKTR 3.0M
  • PLBC 10.8K
  • Earning Date
  • NKTR 03-07-2025
  • PLBC 04-16-2025
  • Dividend Yield
  • NKTR N/A
  • PLBC 2.71%
  • EPS Growth
  • NKTR N/A
  • PLBC N/A
  • EPS
  • NKTR N/A
  • PLBC 4.80
  • Revenue
  • NKTR $93,137,000.00
  • PLBC $81,275,000.00
  • Revenue This Year
  • NKTR $12.15
  • PLBC N/A
  • Revenue Next Year
  • NKTR N/A
  • PLBC $22.44
  • P/E Ratio
  • NKTR N/A
  • PLBC $9.22
  • Revenue Growth
  • NKTR 5.53
  • PLBC 4.55
  • 52 Week Low
  • NKTR $0.63
  • PLBC $32.50
  • 52 Week High
  • NKTR $1.93
  • PLBC $51.33
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 53.83
  • PLBC 40.76
  • Support Level
  • NKTR $0.92
  • PLBC $44.43
  • Resistance Level
  • NKTR $1.08
  • PLBC $46.11
  • Average True Range (ATR)
  • NKTR 0.09
  • PLBC 1.09
  • MACD
  • NKTR 0.03
  • PLBC -0.15
  • Stochastic Oscillator
  • NKTR 65.63
  • PLBC 0.00

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About PLBC Plumas Bancorp

Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

Share on Social Networks: